A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).

Octrooi-publicatienummer: WO2017182603

Jaar aanvraag: 2017

Jaar toekenning: 2018

Gevalideerd voor IOF-sleutel: Ja

Toegewezen aan: Universitaire Associatie Brussel